Eagle IP is excited to sponsor and participate in IAM’s IPBC Connect, returning to Zoom for a week of high-level discussions involving the world’s leading IP experts. From 22-26 March, IAM hosted more than 20 individual interactive digital sessions, each designed to facilitate the exchange of information and insight, benchmarking and the sharing of the best practice in key areas of strategic IP value creation.

Our VP Jennifer Che spoke as an IP expert at an open discussion forum about Patent Law Update Asia, happening March 23 at 11AM HKT (March 22, 11PM EST for those in North America).

You can register for as many sessions as you like across the week, building your own schedule. Find out more here: httpss://cvent.me/VnkWam?RefId=Sponsor

我们的过去活动

Recommended Insights

China Top 50 Case of 2019: How a Functional Feature is Construed Greatly Impacts Protection Scope - Shimano KK v. SENSAH

2020年7月20日
Every year in the spring The Supreme People’s Court of PRC announces its “Top 10 Intellectual Property (IP) cases” and “50 typical IP cases in Chinese courts” of the year. Although not having precedential weight, these cases serve as a reference and guide people's courts at all levels regarding their intellectual property trials. It’s always […]

Updates on Hong Kong Patents Examination Guidelines in 2024

2024年2月29日
The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) […]

Do Invention and UM Patents Filed on the Same Day Rise and Fall Together?

2021年8月19日
Snippets of Court Cases, Provisions, and Key Observations about China’s IP Landscape Seminal Cases by the SPC Recently, the Intellectual Property Division of the Supreme People's Court (SPC) issued a list of seminal (精品) cases. Although China is not a case law country, such seminal cases issued by the SPC have high guiding impact for […]

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

2025年3月10日
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]
Top crossarrow-right